Deltagen Stock Performance
| DGEN Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Deltagen are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Deltagen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Deltagen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
Deltagen |
Deltagen Relative Risk vs. Return Landscape
If you would invest 0.01 in Deltagen on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Deltagen or generate 0.0% return on investment over 90 days. Deltagen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Deltagen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Deltagen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Deltagen's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Deltagen, and traders can use it to determine the average amount a Deltagen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DGEN |
Based on monthly moving average Deltagen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Deltagen by adding Deltagen to a well-diversified portfolio.
Deltagen Fundamentals Growth
Deltagen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Deltagen, and Deltagen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Deltagen Pink Sheet performance.
| Return On Equity | -0.0272 | |||
| Return On Asset | -0.0158 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 71.64 K | |||
| Price To Sales | 0.04 X | |||
| Revenue | 770 K | |||
| Cash And Equivalents | 23 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.05 X | |||
| Cash Flow From Operations | 24 K | |||
| Total Asset | 1.8 M | |||
| Retained Earnings | (224.28 M) | |||
| Current Asset | 7.53 M | |||
| Current Liabilities | 32.64 M | |||
About Deltagen Performance
By examining Deltagen's fundamental ratios, stakeholders can obtain critical insights into Deltagen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Deltagen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company was founded in 1997 and is headquartered in San Mateo, California. Deltagen operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.Things to note about Deltagen performance evaluation
Checking the ongoing alerts about Deltagen for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Deltagen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Deltagen generated a negative expected return over the last 90 days | |
| Deltagen has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 770 K. Net Loss for the year was (46 K) with profit before overhead, payroll, taxes, and interest of 766 K. |
- Analyzing Deltagen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Deltagen's stock is overvalued or undervalued compared to its peers.
- Examining Deltagen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Deltagen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Deltagen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Deltagen's pink sheet. These opinions can provide insight into Deltagen's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Deltagen Pink Sheet
Deltagen financial ratios help investors to determine whether Deltagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deltagen with respect to the benefits of owning Deltagen security.